Exercise Interventions for Metastatic Castrate-Sensitive Prostate Cancer
This study, called Prostate 006, is looking at two different home-based exercise programs for men with newly diagnosed metastatic castrate-sensitive prostate cancer (mCSPC) who are starting ADT (Androgen Deprivation Therapy) or ARSI (Androgen-Receptor Signaling Inhibitors). You would be randomly assigned to either a walking program or a high-intensity interval training (HIIT) cycling program. The main goal is to see how many participants complete their assigned exercise program and how satisfied they are. Researchers also want to learn if these exercises can improve fitness and muscle strength, and if that helps with feeling tired during cancer treatment. The study plans to enroll 24 men aged 18 or older with mCSPC.
- Study design
- This is an interventional study where 24 participants will be randomly assigned to one of two home-based exercise programs.
- What's involved
- You will have 1-2 training sessions at UVA, then exercise at home for 12 weeks. You will also complete aerobic and strength tests before and after the program, and answer questionnaires.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will have a follow-up assessment 14 weeks from the start of the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Paul Viscuse, MD · PRINCIPAL_INVESTIGATOR · University of Virginia
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Number of participants who complete the post-intervention follow-up assessment14 weeks from the start of the intervention
Percentage of participants who complete the post-intervention follow-up assessment